← SynDRA
TROPIFEXOR
SynDRA canonical compound SYN0039799 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | NR1H4 |
|---|
| Mechanism of action | FXR agonist |
|---|
All known targets
Mechanisms of action (all sources)
- NR1H4 AGONIST
- Bile acid receptor FXR agonist
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ABL1
- NEIL2
- TRIM24
- TDG
- SMUG1
- RXRA
- OGG1
- NTHL1
- NR5A1
- NR4A1
- NR2E1
- NR2C1
- NEIL1
- AURKA
- MUTYH
- MBD4
- MAPK1
- HNF4A
- GSK3B
- FGFR3
- CSNK1D
- CDK2
- BRPF1
- BRD4
- UNG
Cross-references
Synonyms
- LJN-452
- LJN452
- NVP-LJN452-NXA
- UNII-NMZ08KM76Z
- NMZ08KM76Z
- CPD1549
- Tropifexor [INN]
- GTPL9725
- SCHEMBL19178329
- SCHEMBL17848159
- EX-A1934
- CS-8153
- compound 1 [PMID: 29148806]
- ACN-053193
- AC-30341
- 2-[(1R,3r,5S)-3-({5-cyclopropyl-3-[2-(trifluoromethoxy)phenyl]-1,2-oxazol-4-yl}methoxy)-8-azabicyclo[3.2.1]octan-8-yl]-4-fluoro-1,3-benzothiazole-6-carboxylic acid
- HY-107418
- 2-((1R,5S)-3-((5-cyclopropyl-3-(2-(trifluoromethoxy)phenyl)isoxazol-4-yl)methoxy)-8-azabicyclo[3.2.1]octan-8-yl)-4-fluorob
- Ljn452
- RefChem:201490
- Tropifexor [USAN]
- Tropifexor (LJN452)
- Tropifexor (USAN)
- LJN452; Tropifexor
- Tropifexor [WHO-DD]
- Tropifexor [USAN:INN]
- Tropifexor (LJN452)?
- orb1302905
- C29H25F4N3O5S
- SCHEMBL20788139
- SCHEMBL29464835
- VYLOOGHLKSNNEK-JWTNVVGKSA-N
- VYLOOGHLKSNNEK-PIIMJCKOSA-N
- BDBM50527040
- MFCD31619256
- s8733
- WHO 10443
- AKOS037648712
- NCGC00689080-01
Look up TROPIFEXOR in the interactive SynDRA portal →